IRIS
SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.165
AS - Asia 1.355
EU - Europa 678
SA - Sud America 364
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 39
OC - Oceania 7
Totale 4.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.094
SG - Singapore 384
BR - Brasile 287
IT - Italia 267
BD - Bangladesh 218
CN - Cina 205
HK - Hong Kong 197
TR - Turchia 138
IE - Irlanda 131
VN - Vietnam 92
FR - Francia 69
DE - Germania 57
GB - Regno Unito 38
CA - Canada 32
AR - Argentina 28
MX - Messico 26
NL - Olanda 26
IN - India 23
PL - Polonia 20
EC - Ecuador 18
ZA - Sudafrica 16
AT - Austria 14
FI - Finlandia 12
ID - Indonesia 12
IQ - Iraq 12
CO - Colombia 11
IL - Israele 10
PY - Paraguay 8
SA - Arabia Saudita 8
SE - Svezia 8
JP - Giappone 7
PK - Pakistan 7
AU - Australia 6
MA - Marocco 6
UZ - Uzbekistan 6
EG - Egitto 5
GR - Grecia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
ES - Italia 4
JM - Giamaica 4
KR - Corea 4
MY - Malesia 4
RU - Federazione Russa 4
TN - Tunisia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
LV - Lettonia 2
PA - Panama 2
TH - Thailandia 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.609
Salva come PNG Salva come JPEG
Città #
Dallas 906
San Jose 201
Hong Kong 193
Ashburn 163
Singapore 161
Dublin 131
The Dalles 95
Santa Clara 69
Beijing 67
Istanbul 66
Boardman 61
Chicago 58
New York 49
Los Angeles 45
Ankara 43
Ho Chi Minh City 32
Rome 24
São Paulo 24
Hanoi 21
Frankfurt am Main 18
Hillsboro 17
Warsaw 17
Naples 16
Milan 15
Phoenix 14
San Francisco 14
Amsterdam 13
Council Bluffs 13
Mexico City 13
Munich 13
Rio de Janeiro 12
Buffalo 11
Chennai 10
Helsinki 10
Rimini 10
Vienna 9
Brasília 8
Paris 8
York 8
Brooklyn 7
Haiphong 7
Johannesburg 7
Mishmar HaShiv`a 7
Orem 7
Palermo 7
Seattle 7
Assago 6
Bologna 6
Bursa 6
Catania 6
Curitiba 6
Fortaleza 6
Nuremberg 6
Reston 6
Stockholm 6
Tashkent 6
Toronto 6
Athens 5
Düsseldorf 5
Guangzhou 5
Guayaquil 5
Limburg an der Lahn 5
Nijmegen 5
Quito 5
Recife 5
Atlanta 4
Belo Horizonte 4
Boston 4
Cairo 4
Denver 4
Divinópolis 4
Florence 4
London 4
Modena 4
Pasadena 4
Riccione 4
Seoul 4
Sydney 4
Thái Bình 4
Tokyo 4
Turin 4
Verona 4
Asunción 3
Bari 3
Biên Hòa 3
Brescia 3
Brno 3
Buenos Aires 3
Campo Grande 3
City of London 3
Cosenza 3
Dammam 3
Denizli 3
Dhaka 3
Erbil 3
Ferrara 3
Goiânia 3
Hangzhou 3
Lauterbourg 3
Lima 3
Totale 2.935
Salva come PNG Salva come JPEG
Nome #
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 582
Anhedonia: Current and future treatments 130
Understanding and treating postpartum depression: a narrative review 101
Depression: Understanding and Managing Antidepressant Side Effects 99
A comprehensive overview of post-stroke depression treatment options 98
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 96
Resistance to Change from a Psychological Perspective 85
Treatment-Resistant Depression: When and How Should It Be Referred? 82
Expanding treatment domains across psychiatric disorders 81
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation 80
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.] 78
A Clinically Oriented Review of New Antipsychotics for Schizophrenia 76
Suicide ideation and male-female differences in major depressive disorder 76
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence 75
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 75
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 74
Anhedonia and Depressive Disorders 72
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance 72
Mental fatigue in individuals with psychiatric disorders: a scoping review 71
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting 69
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors 67
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 66
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 63
A Critical View on New and Future Antidepressants 63
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 63
Genomics yields biological and phenotypic insights into bipolar disorder 62
Understanding mood disorder treatments 61
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology 61
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two {UK} cohorts 60
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets? 59
Age as a moderating factor of treatment resistance in depression 59
Afternoon Keynote Genetic and Clinical Predictors of Antidepressant Response 59
Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders 59
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics 58
Anhedonia is associated with a specific depression profile and poor antidepressant response 58
Antidepressant treatment in complex clinical pictures 57
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality 56
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors 55
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 53
Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank 50
The pharmacological management of treatment-resistant depression: what does the future hold? 50
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 50
Focus on neurodevelopmental conditions and antipsychotics prescription patterns 48
Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine 48
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 48
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path 48
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments 46
Mirtazapine blood levels and antidepressant response 45
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient 42
The clinical perspective on late-onset depression in European real-world treatment settings 41
Mood disorders and somatic comorbidities 35
Psychological impact of neovagina creation and uterus transplantation in the patients affected from Mayer–Rokitanski–Kuster–Hauser syndrome: A narrative review 35
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis 34
Modulating factors in mood disorders treatment 34
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder 34
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders 32
Clinical predictors of treatment resistant depression 32
Shared genetics and causal relationship between sociability and the brain's default mode network 29
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 27
Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review 27
Passive suicide ideation in major depressive disorder: prognostic role and effect of antidepressant treatment 24
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study 23
The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature 23
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis 23
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 20
Further evidence of depressive symptomatology profile predicting treatment outcome 20
Moving toward precision and personalized treatment strategies in psychiatry 20
Defining and assessing international classification of disease suicidality phenotypes for genetic studies 20
Oropharyngeal microbiota in patients with psychotic disorders: A scoping review on compositional and functional alterations 19
Insulin resistance and poorer treatment outcomes in depression: Evidence from UK Biobank primary care data 19
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group 19
Mild motor signs and depression: more than just medication side effects? 19
Schizophrenia Genetics Modulates Clinical Depressive Features 19
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood Disorders 18
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data 18
Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice 18
Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review 17
The impact of depression on functioning: Relation to medication response and other predictors 16
Fine-mapping genomic loci refines bipolar disorder risk genes 16
Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions 16
Neuropsychiatric Symptoms and Alzheimer’s Disease Severity. A Focus on Sex-Differences 15
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis 15
Innovations and challenges in antipsychotic treatments and external modulating factors 15
Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson’s disease and Lewy bodies dementia 14
Symptom networks in major depressive disorder and treatment response: special focus on TRD 14
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectiveness 14
Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation 13
Differences in emotion recognition between nonimmersive versus immersive virtual reality: Preliminary findings in schizophrenia and bipolar disorder 12
Treatment options for depression in Parkinson's disease: a mini-review 12
Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts 12
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients 11
The genetics of treatment-resistant depression: controversies and perspectives 11
Unsolved Issues in Anhedonia: A Call for Targeted Inquiry 11
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways 10
Factors associated with drug–drug interactions involving citalopram in the UK Biobank 9
Totale 4.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.796
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024229 0 0 0 0 0 0 0 17 30 37 80 65
2024/2025917 45 26 39 31 86 55 33 41 178 180 144 59
2025/20263.377 138 418 738 252 84 172 201 331 292 308 237 206
2026/2027198 79 119 0 0 0 0 0 0 0 0 0 0
Totale 4.721